BRIEF-Pacira Pharmaceuticals to pay termination fee of about $7.3 mln to CrossLink
July 01, 2016 at 08:04 AM EDT
* In connection with termination of agreement, fee based on percentage of earned performance-based fees will be due to CrossLink
